Leerink lowers Gilead Sciences’ target price to $127
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
GLONGHUI July 21｜Leerink Partners has lowered Gilead Sciences' target price from $146 to $127 and downgraded its rating from "Outperform" to "Market Perform", as the market growth for its HIV preventive medication faces headwinds.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
Japan's economy grows slower than expected in April-June
Reuters•2026/08/17 00:12
2-Yr Benchmark Govt Yields - U.S. vs Other Nations
Dow Jones•2026/08/17 00:10
10-Yr Benchmark Govt Yields - U.S. vs Other Nations
Dow Jones•2026/08/17 00:10
2-Yr Benchmark Govt Yields - Germany vs Other Nations
Dow Jones•2026/08/17 00:10
Crypto prices
More
Bitcoin
BTC
$62,747.51
-0.41%
Ethereum
ETH
$1,871.86
-0.47%
Tether USDt
USDT
$0.9989
+0.00%
USDC
USDC
$0.9999
+0.01%
XRP
XRP
$0.9901
-1.09%
Solana
SOL
$74.49
-1.06%
TRON
TRX
$0.3309
+0.01%
Hyperliquid
HYPE
$57.21
+0.80%
Dogecoin
DOGE
$0.06952
-0.02%
Zcash
ZEC
$485.44
-0.24%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now